Higher doses tended to result in more weight loss compared to placebo
GLP-1 medications like Mounjaro (tirzepatide) and Wegovy (semaglutide) reduce hunger and cravings, helping us lose weight by eating fewer calories
Potential Benefits: Significant weight loss (mean 1015% body weight reduction in clinical trials at 2.4 mg weekly dose) when combined with lifestyle modifications [1] [5]
In the long term, as patent expirations allow for generic competition, the cost of the active ingredient for both pills and injections is expected to decrease, improving coverage and affordability
We're terrified that patients are going to use too much healthcare, and like everybody's got Munchausen disease
Although GLP-1 medications can lead to significant weight loss, they don't work for everyone, Dr